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CHAPTER I 
INTRODUCTION 
The Role of Glycoproteins in Oncogenesis 
In order to understand the importance of glycoproteins in neoplastic 
disease, one must first be cognizant of their normal functions. Thus, it 
is advantageous to consider the general role of cell surface glycoproteins 
before discussing glycoproteins and cancer or the importance of glycopro-
teins in tumor immunology. One must also consider other facets of 
cancer development, including abnormal membrane turnover and metastasis. 
Careful analysis of specific tumor systems such as the TA3 mammary 
carcinoma and the 13762 rat mammary adenocarcinoma enables the individual 
to gain a clearer understanding of the complex, often deadly, diseases 
known as cancer. 
Cell Surface Glycoproteins 
Cell surface glycoproteins have been implicated in many important 
biological processes, including cell recognition and adhesion (Edwards, 
1978), contact inhibition (Knecht, 1977), embryological development 
(Mintz and Glaser, 1978; Parish and Schmidlin, 1979) and membrane 
transport (Olden et al., 1979; reviews: Hughes, 1976; Glick and Flowers, 
1978). The plasma membrane is enriched in this class of proteins, and 
glycoproteins have a definite topographical organization in this membrane. 
1 
The carbohydrate residues are generally confined to that end of the pro-
tein which is exposed on the external surface of the lipid bilayer 
(Marchesi~ al., 1972; Hirano et al., 1972; Singer, 1974). 
2 
Current evidence indicates that the oligosaccharide portion of 
glycoproteins is important for protein secretion (Eylar, 1965), specific 
recognition of serum glycoproteins (Lunney and Ashwell, 1976), protection 
of glycoproteins against proteolytic degradation (Olden, Pratt and Yamada, 
1978), the insertion or proper orientation of glycoproteins in the 
plasma membrane (Pouyssegur and Pastan, 1976; Hughes et al., 1977), and 
for cell adhesion and determining cell morphology (Duksin and Bornstein, 
1977). Despite this importance, glycoprotein structure-function relation-
ships are not well understood. 
Glycoproteins and Cancer 
During the last decade, many investigators have found changes in 
cell surface glycoproteins associated with oncogenesis. Cell surface 
glycoprotein differences between normal and malignant cells in culture 
have been demonstrated by analysis of chromatographic patterns of 
glycoproteins released from the cell surfaces with trypsin and degraded 
with Pronase (Buck, Glick and Warren, 1971). 
Interest in the relationship of glycoproteins to cancer arose out 
of the observation that patients with neoplastic disease had elevated 
plasma levels of protein-bound carbohydrate (Winkler and Bekesi, 1970). 
Subsequent investigations in many different laboratories have generally 
substantiated this finding, and there are some indications that there 
.may be very specific glycoprotein changes characteristic of some types 
of malignant tumors (Bramwell and Harris, 1978). Antigens common to 
3 
cell surfaces of several human melanomas have been detected (Bystryn 
and Smalley, 1977), and a common and identical antigen has been isolated 
from two distinct human lung tumor extracts (Gaffer et al., 1979). 
Furthermore, certain plant lectins which bind specifically to 
carbohydrates will cause agglutination of many malignant cells at a 
much lower lectin concentration than required to agglutinate their non-
malignant counterparts (Burger, 1973). Agglutination, however, is a 
c~mplex process which involves more than the number of lectin binding 
sites on a cell surface (reviews: Nicolson, 1974; Kornfeld and Kornfeld, 
1978). 
Peanut lectin, specific for terminal D-galactosyl residues (D-Gal-
j)(1~3)-GalNAc), is especially noteworthy. This oligosaccharide structure 
is found on the Thomsen-Friedenrich antigen (T-antigen) which is a 
precursor of the M and N blood-group antigens. According to present 
knowledge, T-antigen does not occur in unmasked form in healthy human 
tissues. However, this precursor T-antigen has been demonstrable in 
malignant tissue, but not in benign lesions or normal tissue, from 
human mammary glands. T-antigen has also been found in the epithelial 
layer of human stomach carcinoma and two human colon carcinoma-derived 
tissue culture lines (reviewed by Springer, 1977). Freeman and Kim 
(Cancer Bulletin) found that anti-T antibody level is severely depressed 
in patients with malignant breast and gastrointestinal epithelial tissues. 
However, they were unable to distinguish between decreased antibody 
synthesis and continuous preferential in vivo absorption of anti-T by 
the T-antigens in malignant tissues. 
The possible role of glycosyltransferases, in particular cell sur-
face glycosyltransferases, in neoplastic phenomena has been a source of 
considerable controversy. Warren~ al. (1973) attributed the glyco-
peptide differences that they observed between normal and malignant 
cells in culture to differences in a specific sialyltransferase activity 
between the cell lines, while Bosmann and Hilf (1974) have shown an 
elevated serum sialyltransferase activity in a transplantable mammary 
tumor. 
Bauer ~ al. (1977b) have found that specific alterations of fucose 
metabolism are a characteristic feature of Morris hepatomas and have 
suggested that the OC-3-fucosyltransferase activity of human serum can 
be used as an indicator of malignancy (Bauer et al., 1977a). Bauer 
et al. (1978) have also shown a decrease of human serum fucosyltransfer-
ase associated with successful tumor therapy. Furthermore, Chatterjee 
and Kim (1978) have established a link between a 6-7 fold increase in a 
fucosyltransferase level and metastasis of six metastasizing rat 
mammary tumors compared to four nonmetastasizing strains. Whether or 
not such correlations are true of malignancy in general remains to be 
seen. 
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One might expect enhanced degradation qf glycoproteins at the surface 
of tumors to account for their lack of cohesiveness and apparent weakeried 
cell-cell interactions. Acceleration of these processes could be reson-
sible for the initial step in metastasis, through the release of some 
cancer cells from the primary tumor .. Kim et al. (1975) have shown a 
correlation between metastasizing ability and absence of glycoprotein 
coat for a series of mammary tumors. Such changes at the cell surface 
may be related to the immunogenicity of the tumors. It has been suggested 
that proteolysis is important for growth inhibition due to high cell 
densities. Some tumors and transformed cells elicit a fibrinogen 
5 
activator (Unkeless et al., 1974), but this may not be related to growth 
inhibition (Matt et al., 1974). Changes in cell surface glycoproteins 
in transformed cells might be explained by action of proteases (Hynes, 
1974). Likewise the glycoprotein differences described by Shin~ al. 
(1975) in the R3230 Ac mammary tumor could have arisen from surface pro-
teolysis. 
Glycoproteins and Tumor Immunology 
Because glycoproteins are major components of tumor (and normal) 
cell surfaces, it is logical to expect that they may play a role in the 
immune response of the host to the tumor. They may act as antigens 
themselves or as "masking agents" which block access to transplantation 
antigens, as proposed by Codington ~ al. (1973) for the TA3 mammary 
carcinoma. 
In fact, most experimentally induced animal tumors and many human 
neoplasms express tumor-associated-antigens (Oettgen et al., 1972). 
Some of these are tumor specific transplantation antigens (TSTA), 
defined by their ability to induce an immune reaction which will lead to 
the rejection of transplanted neoplastic cells by the appropriately 
immune host (Old and Boyse, 1964; Sjogren, 1965). Other antigens do not 
function as TSTA but may be demonstrated by sensitive in vitro techniques 
(Hellstrom and Hellstrom, 1969). Phase specific (embryonic) tumor 
antigens shared by neoplastic and normal embryonic cells are examples 
of antigens which belong primarily to the latter group (Alexander, 1972). 
Still other tumors may not have any detectable antigens not also present 
on the corresponding normal cells. 
Direct evidence for the involvement of cell surface carbohydrate 
in the immune response is available from studies on the 11210 mouse 
leukemia (Bekesi et al., 1972). This tumor is readily transplantable 
under normal conditions, but is rejected if treated with neuraminidase 
before implantation. Neuraminidase treated cells are highly immunogenic 
and can be used for immunization of the murine host against subsequent 
tumor transplants. This phenomenon is not unique to cancer cells. The 
early mouse trophoblast may owe its privileged immunological position 
to a sialomucoprotein layer coating the trophoblastic epithelium (Currie 
et al., 1968). Neuraminidase treatment of ectoplacental cone cells 
11unmasks" the presence of transplantation antigens and reveals that 
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there is no- intrinsic deficit of such antigens in early mouse trophoblast. 
As mentioned previously, Kim~ al. (1975) have suggested that metastasi-
zing tumors have lost their glycocalyx, which was postulated to act as 
an antigen on the tumor cells. Isolated membranes and released 
glycoprotein materials were immunogenic in the rabbit and showed similar 
antigens. However, this does not establish their immunogenicity in the 
host. 
The shedding of tumor antigens in general has been described by 
many authors (Rittenhouse~ al., 1978; Lopez and Thomsen, 1977; Raz et 
al., 1978; Bystryn, 1977). One should consider what role they play in 
permitting the survival of the tumor from destruction by the immune system. 
One possibility is that the loss of cell surface antigens renders 
the cell unrecognizable as a foreign entity. A more likely mechanism, 
however, is that the materials "shed" from the cell surface combine with 
essential components of the immune system to render the1n inoperative. 
Thus, specific blocking factors (SBF) are defined as any humoral factors 
which can, in a specific way, impair an immune response to tumor antigens, 
independent of their site of action and their molecular composition. 
SBF may be tumor products, antigen-antibody complexes or T-cell derived 
suppressor molecules. The importance of SBF has been recently reviewed 
(Hellstrom et_ al., 1977). There have been reports from several labora-
tories that SBF from mouse sarcomas inoculated into syngeneic animals 
can enhance the growth of tumor cells having the respective antigenic 
specificity (Pierce, 1971; Ran and Witz, 1972; Bansal et al., 1972). 
However, the nature of this blocking effect has not been completely 
deciphered. 
Membrane Turnover 
Warren (1969) proposed that surface membrane turnover might be an 
important aspect of the abnormal properties of tumors. Relatively 
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little work has been done in the area of glycoprotein turnover and 
release from mammalian cells, because of the complexities of the membrane, 
the number of glycoproteins involved and the difficulties of isolating 
individual components for analysis. Schimke (1975) has reviewed the 
important aspects of protein turnover in animal cells, including method-
ology. Atkinson (1975) reported an investigation focused on turnover 
of fucosyl glycoproteins ·in animal cells. The results indicate that 
there is a significant internal pool of fucose-containing glycoprotein 
which is assembled into the membrane independently of nonfucosylated 
membrane proteins. Based on their research using hepatoma tissue culture 
cells, Doyle et al. (1978) have proposed that, during biogenesis, 
fucose-containing glycoproteins of the cell are assembled as a membrane-
limited structure in the intracellular compartment. Part of this presyn-
thesized membrane is then supplied directly to the plasma membrane, 
but part of it is added to a relatively large internal pool of 
membrane also having the same glycoprotein composition as the plasma 
membrane. Dual label experiments utilizing a neuroblastoma cell line 
have shown that numerous surface glycoproteins are metabolized more 
rapidly or slowly than most of the cell surface constituents (Hudson and 
Johnson, 1977). Glycoproteins turning over more rapidly than other 
membrane components have also been observed in other cell systems 
(Goldberg, 1974). 
Metastasis 
Tumor metastasis is clinically one of the most grave aspects of 
cancer. The spread of tumor cells from the primary site to secondary 
sites occurs through the circulatory system, lymphatics or coelomic 
cavities (Coman, 1953; Zeidman, 1957). Free tumor cells or their aggre-
gates in the blood will lodge in the first capillary bed they encounter, 
but may then re-enter the circulation and stop in other organs (Fisher 
and Fisher, 1967). Location of secondaries is dependent on the 
particular tumor type and is not necessarily a random process. Such 
behavior indicates that discrete tumor cell properties are responsible 
for the metastasizing ability of tumors. The importance of tissue 
dissociation and cell-cell interactions in the overall metastatic 
process indicates that the cell surface properties may be critical to 
metastasis. This hypothesis is supported by the work of Nicolson and 
Winkelhake (1975) on the relationship of the organ specificity of blood-
born tumor metastases to cell adhesion and by the previously mentioned 
studies of Kim et al. (1975) on the correlation between metastasizing 
capability and glycocalyx. Cell surface phenomena clearly must be 
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involved in both the dissociation of the tumor cell from its primary 
site and its association with a new site. 
However, neither invasion nor metastasis is peculiar to cancer; 
both phenomena are exemplified by '.the developing placenta and the spread 
to the liver and lungs of fragments of chorionic tissue which may 
implant and grow but which, with the cessation of the pregnancy, die 
. and disappear. What is peculiar to cancer is the ability of the 
disseminated cells to continue to divide and thus increase in bulk 
(Davies, 1977). 
TA3 Mammary Carcinoma 
9 
The TA3 mammary carcinoma sublines TA3-Ha and TA3-St have been 
studied extensively by Codington and coworkers. Epiglycanin is the 
sialoglycoprotein found in abundance on the TA3-Ha mammary adenocarcino-
ma, an allotransplantable subline which will also transplant across 
species barriers (Miller et al., 1977). It is virtually absent from the 
strain-specific TA3-St subline, leading to the suggestion that the 
glycoprotein epiglycanin is the factor responsible for transplantability 
differences by virtue of its ability to block access to transplantation 
antigens (Sanford et al., 1973). Epiglycanin content of cells or fluids 
can be assayed by its reaction with Vicia graminea lectin (Codington 
et al., 1975). The glycoprotein is found in ascites fluids of the tumors, 
suggesting that it is shed from the cells (Cooper, Codington and Brown, 
1974). The overall release of epiglycanin in vitro is biphasic (Miller 
and Cooper, 1978). When the TA3-Ha ascites cells were grown in 
suspension culture, epiglycanin gradually diminished such that after 
7-10 days only 50% remained and after 2 months only 10% was detected. 
Repassage of the cultured cells in vivo cuased the gradual reappearance 
of the glycoprotein (Miller~ al., 1975). Most of the work on the 
glycoprotein itself has been done on fragments released from the cells 
by proteolysis (Codington ~ al., 1972). The fragments are large 
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(5 x 105 daltons) and form long rod-like structures (Slayter and 
Codington, 1973). Composition studies show 70% carbohydrate and 30% 
protein with sialic acid, N-acetylglucosamine (NAG), N-acetylgalactos-
amine (NA-Gal) and galactose as the predominant sugars. Threonine and 
serine are the primary amino acids. In 6 M guanidine two components 
were found. The molecular weights were 88 K and 180 K by gel filtration 
and 138 K and 308 K by sedimentation equilibrium. Epiglycanin can be 
visualized by transmission electron microscopy as fibrils extending 
from.the surfaces of microvilli of the TA3-Ha cells. It can also be 
visualized by staining with cationized ferritin (Miller, Hay and 
Codington, 1977). However, little is known about its mode of association 
with the membrane. The TA3-Ha cells tend to be poorly agglutinable 
with many lectins, including Con A, while the TA3-St cells are readily 
agglutinable (Friberg et al., 1974). 
Glycophorin 
The most studied cell surface glycoprotein has been glycophorin, 
the major sialoglycoprotein of the human erythrocyte membrane (Marchesi 
~ al., 1972). It is an integral protein, firmly bound to the membrane, 
which requires detergent or organic solvent treatment to release it 
from the membrane (Marchesi and Andrews, 1971; Blumenfeld and Zvilichovsky, 
1972). Its amino acid sequence has been determined and consists of 
a 64-residue N-terminal sequence that bears the carbohydrate, a 32-
residue internal hydrophobic sequence and a 35-residue C-terminal 
sequence (Tomita and Marchesi, 1975). It has been proposed that the 
molecule extends through the membrane with the internal sequence 
interacting with the lipid bilayer. The state of aggregation in the 
membrane is uncertain. Two predominant forms are seen on SDS-electro-
phoresis and appear to be a monomer and dimer in equilibrium (Marton 
and Garvin, 1973). The equilibrium can be shifted by changing the 
solubilization or electrophoresis conditions or by chemical modification 
of the protein (Silverberg, Chow and Marchesi, 1977). From both compo-
sition and sedimentation determinations the molecular weight is 31,000 
of which approximately 55% is carbohydrate. Glycophorin is rich in 
sialic acid, galactose and NA-gal and has lesser amounts of NAG, fucose 
and mannose (Hudson et al., 1975). At least two types of oligosaccharide 
chains are present. One is a four unit "mucin-like" structure (Thomas 
and Winzler, 1969), while the other is a larger "plasma" type (Thomas 
and Winzler, 1971). 
Previous Work on the 13762 Adenocarcinoma 
Sublines 
The 13762 rat mammary adenocarcinoma is a dtmethylbenzanthrene 
induced solid tumor (Segaloff, 1966). The tumor was adapted for ascites 
growth by Bogden at Mason Research Institute (Tumor Bank Inventory). He 
was able to isolate three pharmacologically distinct sublines: MAT-A, 
MAT-B and MAT-C. In addition, a cell culture line, MR, was derived from 
the MAT-B ascites line by growth in soft agar. 
After a number of passages in Carraway's laboratory, the MAT-Band 
MAT-C ascites lines became the more stable MAT-B1 and MAT-C1 lines used 
in this investigation. Histopathological examination confirms that 
these lines are still adenocarcinomas. 
By scanning electron microscopy MAT-C1 cells exhibit a highly 
irregular surface, covered with microvilli extending as branched struc-
tures from the cell body. MAT-B1 cells have a more normal appearance, 
with unbranched microvilli, ruffles, ridges and blebs associated 
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closely with the cell body (Sherblom et al., 1980c). Both MAT-B1 
(nonxenotransplantable) and MAT-C1 (xenotransplantable) ascites sublines 
contain a major sialoglycoprotein (ASGP-1) with low electrophoretic 
mobility in dodecyl sulfate. ASGP-1 has been purified from membrane 
vesicles by extraction with 4 M guanidine hydrochloride. The composition 
of ASGP-1 from each subline is high in serine, threonine, galactosamine, 
glucosamine, galactose and sialic acid with carbohydrate compositions 
of 67% and 73% for MAT-B1 and MAT-C1, respectively. Amino acid composi-
tions of ASGP-1 from the sublines are essentially the same. The major 
difference between them is a 3-fold greater content of sialic acid per 
unit protein for MAT-C1 ASGP-1 than MAT-Bl ASGP-1. Molecular weights of 
570,000 (MAT-Bl) and 690,000 (MAT-C1) were estimated by sedimentation 
velocity analysis and gel filtration in 4 M guanidine hydrochloride. 
Fractionation of oligosaccharides from alkaline-borohydride treated 
ASGP-1 on Biogel P4 gives patterns that are quantitatively different 
for MAT-B1 and MAT-C1 (Sherblom, Buck and Carraway, 1980a). ASGP-1 
from MAT-B1 cells is also labeled by r5s]sulfate, but MAT-Cl ASGP-1 
is not. Treatment of the ascites cells with trypsin releases about 30% 
of the total cell sialic acid without significant decrease in cell 
viability (Buck, Sherblom and Carraway, 1979). 
Although both sublines bind concanavalin A, the MAT-Bl cells are 
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readily agglutinated and show distinct receptor redistribution, whereas 
the MAT-C1 cells are not agglutinated and do not show long range 
receptor redistribution (Carraway et al., 1978). 
It is thought that the composition of the ASGP-1 oligosaccharides 
may be an important factor determining the ability of the sublines to 
be transplanted across species histocompatabilfty barriers (Sherblom 
Buck and Carraway, 1980a). However, other factors, such as the quantity 
and form of ASGP-1 shed in vivo or the rate of clearance of ASGP-1 from 
serum, may also be important. 
CHAPTER II 
CHANGES IN EXPRESSION OF A MAJOR 
SIALOGLYCOPROTEIN ASSOCIATED 
WITH ASCITES FORMS OF A 
MAMMARY ADENOCARCINOMA 
Introduction 
Ascites sublines of the 13762 rat mammary adenocarcinoma have a 
dominant, large sialoglycoprotein (ASGP-1) located on their cell sur-
faces (Carraway et al., 1978; Sherblom, Buck and Carraway, 1980a). 
ASGP-1 is not observed in the solid 13762 tumor from which the ascites 
sublines are derived (Carraway et al., 1978). These results suggest 
that the expression of ASGP-1 is related to the environment or growth 
conditions of the tumor. Somewhat similar results have been obtained 
with the TA3-Ha mouse mammary adenocarcinoma. Subcutaneous injection 
of the TA3-Ha ascites cells caused a solid tumor which had reduced 
amounts of a major sialoglycoprotein (Cooper et al., 1977). Additional 
passages as a solid tumor increased the level of this sialoglycoprotein 
to near that of the ascites form. When TA3-Ha cells were put into culture, 
their level of the sialoglycoprotein decreased substantially (Cooper et 
al., 1977; Miller et al., 1975). 
Since cell surface sialoglycoproteins may be important to the 
survival of tumor cells, we have investigated changes in expression of 
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ASGP-1 in 13762 cells adapted for growth in cell culture (13762 MR). 
The subline in culture does not have detectable ASGP-1. Intraperitoneal 
transplantation produces ascites tumor cells which also do not have 
ASGP-1. However, with continued passage of the tumor in ascites form 
ASGP-1 is produced. No ASGP-1 was found in solid tumors obtained by 
subcutaneous injection of 13762 cells. Morphologically distinct 
clones isolated from the 13762 }ffi showed essentially the same behavior. 
Materials 
McCoy's SA (modified), nonessentail amino acids, fetal calf serum, 
and Penicillin/Streptomycin solution were from Gibco, sodium pyruvate 
was from Microbiological Associates, lactoperoxidase, glucose oxidase 
and PPO (2,5-diphenyloxazole) were from Sigma, [3H]NaBH4 (specific 
activity greater than 100 mCi/mmole) was from New England Nuclear, 
D-l-[3HJglucosamine HCl (2-6 Ci/mmole) and carrier-free [ 125rJNal were 
from Amersham/Searle. Soluene 350 and Instagel were from Packard, the 
Stadie-Riggs Tissue Slicer was from Thomas, and the concanavalin A and 
peanut lectins were from Miles-Yeda, Ltd. 
Methods 
Preparation of Cells 
MAT-Bl, a 13762 rat mammary gland ascites tumor subline (Carraway 
~ al., 1978), was maintained by weekly intraperitoneal injection of 
approximately 2 x 106 cells in 0.25 ml of 0.9% NaCl into 60-90 day old 
female Fisher 344 rats. After 6 or 7 days the ascites cells were recov-
ered from the peritoneal cavity by aspiration and washed three times by 
suspending in Dulbecco's phosphate-buffered saline, pH 7.4 (Dulbecco, 
16 
1954) or Hanks' phosphate-buffered saline (Hanks and Wallace, 1949) and 
centrifuging at 120 g for three minutes. Viability was determined by 
Trypan blue exclusion; only preparations of cells showing viability 
greater than 98% were used. 
13762 solid mammary tumor was maintained in F344 female rats by 
monthly subcutaneous transfer of minced tumor sections using a sterile 
trocar. Tumor cells used in experiments were from three-week tumors 
(approximately 1 em maximum length). 
13762 MR cells, a cell culture variant of MAT-B cells obtained as 
a gift from Dr. Erling Jensen at the Human Cell Culture Bank of Mason 
Research Institute, Rockville, Md., were maintained in serial culture 
in milk dilution bottles in McCoy's SA (modified) minimal essential 
medium (MEM) supplemented with 10% fetal calf serum, nonesential amino 
acids, 1 mM sodium pyruvate and penicillin/streptomycin. Stocks were 
passaged every seven days. Spinner cultures were started from milk 
dilution bottle stocks at a cell density 1-5 x 105 cells/ml three days 
before labeling or harvesting the cells. Cells were pelleted and resus-
pended in fresh media 24 hours before labeling or harvesting. 
Production of Ascites Tumor from 13762 MR 
Ascites tumors were produced from washed 13762 MR spinner culture 
cells suspended in 0.9% NaCl. 5 x 106 cells were injected into the perito-
neal cavity of F344 female rats and grown approximately 14 days for the 
first few passages in the rats. 6 Thereafter, 1.25 x 10 cells were injected 
every seven days. 
Cell Labeling with Periodate-Borohydride 
Labeling with per~odate-borohydride was performed according to the 
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procedure of Gahmberg and Andersson (1977). 7 Cells (1 x 10 ) were 
incubated for 10 minutes on ice in 1 ml of Hanks' PBS, pH 7.4, contain-
ing 2 mM sodium periodate; the reaction was quenched by addition of 0.2 
ml of 0.1 M glycerol in PBS, and cells were washed once with Hanks' PBS, 
pH 8.0. The sample was suspended in 1 ml of the same buffer and incuba-
. 3 
ted for 30 minutes at room temperature with 0.25 mCi [ HJNaBH4 . 
Unlabeled NaBH4 (0.1 mg) was added,. and the cells were washed twice in 
the pH 8.0 buffer and once with PBS, pH 7.4. 
Lactoperoxidase-Catalyzed Iodination 
Lactoperoxidase-catalyzed iodination was performed according to the 
method of Hynes (1973). Carrier-free 1251 (0.1 mCi), lactoperoxidase 
(40 pg) and glucose oxidase (0.2 units) were added to a suspension of 
1 ~ 107 cells in 1 ml of Hanks' PBS, pH 7.4, containing 1 mg/ml glucose. 
After incubation at room temperature for 10 minutes, cells were washed 
three times with PBS, pH 7.4 to which 1 rnM KI was added. 
[ 3H1Glucosamine Labeling of Cells 
Tritiated glucosamine (5 pCi/ml concentration) was diluted with 1 ml 
McCoy's SA (modified) and added to the cell culture which was incubated 
with label in a 5% co2 atmosphere for 5-6 hours at 37° before harvesting 
the cells. The cells were washed three times with Hanks' PBS, pH 7.4. 
13762 solid tumor was similarily labeled after slicing into 0.5 mm thick 
slices using a Stadie-Riggs tissue unit. 
Plasma Membrane Preparation 
Plasma membranes were prepared by the Zn++ stabilization method 
as reported previously (Carraway et al., 1976) except that 0.1% NaCl 
was added to the 40 mM Tris, pH 7.4, used in the swelling step and the 
incubation in ZnC12 was twelve minutes at room temperature. 
Electrophoresis 
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Labeled whole cells or plasma membranes were solubilized by addition 
of an equal volume of solution containing 0.125 M Tris, pH 6.8, 3% SDS 
(sodium dodecyl sulfate) and 5%yj-mercaptoethanol and immersion in a 
boiling water bath for five minutes. Solubilized whole cells were 
sonicated briefly at low frequency to disrupt viscous material, and 0.1 
volume of 0.02% Pyronin Y in 50% glycerol was added. 
The solubilized cells or plasma membranes were subjected to SDS 
polyacrylamide gel electrophoresis as described previously (Sherblom, 
Buck and Carraway, 1980a; King and Laemmli, 1971). After staining -.;v-ith 
Coomassie blue, gels were soaked 30 minutes in 10% methanol followed by 
10% methanol, 1% glycerol. Gels to be processed for fluorography (those 
with tritiated samples) were soaked in three changes of DMSO (dimethyl 
sulfoxide) (20 minutes each) and 22% PPO in DMSO for 30 minutes (Bonner 
and Laskey, 1974). After a water wash the gels were dried, placed in 
contact with Kodak X-Omat R (XR-5) x-ray film which had been preflashed 
to increase sensitivity (Laskey and Mills, 1975) and stored at -70° for 
7-10 days, except.where otherwise noted. Kodak no-screen film NS-ST was 
used for 1251-autoradiography of slab gels. 
Lectin "staining" of gels with 1251-labeled lectins was performed 
as described previously (Sherblom, Buck and Carraway, 1980a; Burridge, 
1976). 
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Cloning 
A MR cell suspension was diluted to an average of 2 cells/ml and 
5 cells/ml. 0.1 ml was then pipetted into each well of five Costar 
96 well (6.4 mm diameter) tissue culture cluster plates. Medium used 
was 25% preconditioned refiltered McCoy's SA (Tl}odified) plus 10% fetal 
calf serum. Seventeen hours after the dilution, each well was examined 
microscopically. Wells containing only a single cell were marked and 
periodically examined for colony growth. Cultures were maintained in a 
5% co2 atmosphere until the third passage, when they were transferred to 
milk dilution bottles. 
Electron Microscopy 
Cells (107/ml) for scanning electron microscopy were added dropwise 
with shaking to ten volumes of 2% glutaraldehyde in 0.1 M sucrose, 0.1 M 
0 
cacodylate, pH 7.4, at 37 and incubated for 120 minutes. The cells were 
then placed on serum-coated coverslips prepared by incubating sterile 
coverslips in 10% calf serum-MEM (Eagle's minimal essential medium) for 
at least two hours. The cells were allowed to settle onto the coverslips, 
which were left undisturbed at 4° overnight, washed twice in cacodylate-
sucrose buffer and treated with 0.5% osmium tetroxide at room temperature 
for 60 minutes. The samples were dehydrated with a graded series of 
ethanol and dried at the critical point of co2 in a Polaron E3000 critical 
point drying apparatus. The coverslips were mounted on stubs and coated 
0 
with 100 A of gold with a Hummer II. Samples were viewed with a JEOL 
JSM-35 scanning electron microscope operated at 15 KV, and micrographs 
were recorded on Polaroid type 55 negative films. 
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Results 
Description of the Cultured Subline 
The 13762 MR cells were originally isolated by Dr. Erling Jensen 
from the MAT-B ascites form of the 13762 adenocarcinoma. Although the 
cells grow attached to a substratum, a considerable number of them 
release and float in the medium as the cell density increases. Time 
lapse cinematography shm..rs that this release is not due to crowding and 
a failure to find sufficient room to spread after mitosis (Sandra McGuire, 
unpublished observations). Release appears to be a random event. If 
the attached and suspended populations are separated and recultured, the 
same proportion of attached and suspended cells are found when they reach 
the appropriate density. This behavior continued for at least 25 passages, 
indicating that there is no selection for either form. 
The attached and suspended cells have s1milar morphologies by 
scanning electron microscopy (Figure 1). Moreover, cell surface and 
glycoprotein labeling experiments demonstrated no substantial differences 
in cell surface components between attached and suspended cells after 
electrophoresis (Figure 2). Likewise the polypeptides observed by 
Coomassie blue staining were essentially indistinguishable (Figure 3, gels 
C and D). 
To show that the labeling procedures labeled primarily cell surface 
components, plasma membranes were isolated using the Zn++-stabilization 
method (Carraway~ al., 1976). Figure 4 shows that the labeling patterns, 
observed after polyacrylamide gel electrophoresis in dodecyl sulfate, are 
essentially the same for labeled cells and for membranes isolated from 
labeled cells. As expected the polypeptide patterns for cells and 
Figure 1. Scanning Electron Micrographs of Attached (A) and Suspended 
(B) 13762 MR Cells. 5400 x magnification. 
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Figure 2. Comparison of SDS-Polyacrylamide (7.5%) Gel Profiles of MR 
Spinner Cells (A) to MR Cells Attached to Substratum (B). 
Cells are labeled by lactoperoxidase-catalyzed 125I-
iodination (Panel I), periodate [3H]borohydride oxida-
tion-reduction (Panel II), and [3H]glucosamine 
metabolic labeling. The proteins used as molecular 
weight markers were myosin (210 K), phosphorylase (93 K), 
bovine serum albumin (68 K) and ovalbumin (43 K). 
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Figure 3. Polypeptides Determined by SDS-Polyacrylamide (7.5%) Gel 
Electrophoresis of 13762 Solid Tumor (A), l~T-Bl Cells 
(B), MR Attached Cells (C), MR Spinner Cells (D) and 
MAT-MRl-S Ascites Cells (E). 
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Figure 4. Comparison of Labeling, Lectin and Polypeptide Profiles of 
Membranes Isolated form Labeled MR Spinner Culture Cells 
(A) to the Original Cells (B). Labeling was by 
lactoperoxidase catalyzed 125I~iodination (Panel I), 
periodate-(3H]borohydride oxidation-reduction (Panel II), 
[125I]concanavalin A stai~ing (Panel III), and 
coomassie-blue staining (Panel IV). 
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membranes are quite different. 
Effect of Transplantation and Passage in 
Ascites Form on the Glycoproteins of 
13762 HR Cells 
13762 HR cells were transplanted into the peritoneal cavities of 
rats tb give ascites tumors (MAT-MRl) which were passaged in vivo in 
ascites form. After the 16th passage the cells were analyzed by cell 
surface and metabolic labeling and for PNA and Con A receptors. For 
comparison MR and MAT-Bl cells were labeled under the same conditions. 
MAT-Bl was used because it is more stable under our passage conditions 
than MAT-B, from which both MAT-Bl and MR cells were derived. Moreover, 
the cell surface labeling patterns examined in these studies are not 
significantly different for MAT-B and MAT-Bl sublines. The results in 
Figure 5 show that substantial changes have occurred in the glycoproteins 
of the 13762 }ffi cells as a result of transplantation and passage in the 
ascites form. In particular, ASGP-1 is detectable by both metabolic 
labeling and PNA receptor analysis in the ascites cells (MAT-MRl-S) 
derived from transplanted MR cells. Thus the transplantation and passage 
have caused the MAT-MRl-S population to become more similar to the MAT-Bl 
cells than to the MR cells. The change was not limited to ASGP-1. The 
C A "d 125r 1 .d 1 b 1. b h on receptors an - actoperox1 ase a e 1ng patterns are ot more 
similar for MAT-MRl-S and MAT-B1 cells than for MAT-MRl-S and MR cells. 
In addition the polypeptides of both cultured and ascites cells were 
examined by Coomassie blue staining of polyacrylamide gels run in SDS 
(Figure 3). The ~~T-MRl-S ascites cells show more similarities to MAT-B1 
ascites cells than they do to the MR cells (attached or spinner) from 
Figure 5. Comparison of Labeling and Lectin Profiles of MR Spinner 
Culture Cells (A) to MR Transplanted into F344 Female 
Rats and Grovm in Ascites Form, :tvLA.T-MRl-S (B), and to 
MAT-Bl Ascites Cells (C). Cells were labeled by 
lactoperoxidase-catalyzed 125I-iodination (Panel I), 
(125I]Con A staining (Panel II); [125I]PNA staining 
(Panel III), and (3H]glucosamine metabolic labeling 
(Panel IV). Panels III and IV are 4.5-15% acrylamide 
linear gradient slabs. 
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which they were derived, particularly in the 43 K to 60 K region of the 
gel. 
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As shown previously (Huggins~ al., 1980a), slow-migrating glyco-
proteins, which do not show a band for ASGP-1 by density gradient 
centrifugation, can be observed by glucosamine labeling and electrophor-
esis of the 13762 solid tumor. Therefore we examined the labeled 
component from :t:-1AT-HR1-S cells by density gradient centrifugation in CsCl 
and 4 H guanidine hydrochloride. A sharp peak was obtained at a density 
of 1.4 g/ml (Figure 6C), indicating that a glycoprotein with the density 
of ASGP-1 was responsible for the labeling of the :t:-1AT-:t:-1R1-S cells. By 
contrast the HR cells grown in culture (Figure 6D) do not show a defined 
glycoprotein peak by density gradient centrifugation. 
Since neither the :t:-1R nor the 13762 solid tumor has ASGP-1, it was of 
interest to compare them. Substantial differences were found for both 
glucosamine labeling patterns and Con A. receptors (Figure 7), although 
some of the Con A receptors, including the major one, appear to be the 
same. Thus the cell line adapted to cell culture from the ascites form 
does not represent simply a reversion to the form of the solid tumor, at 
least as far as glycoproteins are concerned. 
Loss of ASGP-1 from Ascites Cells after 
Transfer to Cell Culture 
To determine whether the changes in expression of ASGP-1 are reversi-
ble, :t:-1AT-HR1-S cells maintained by continuous passage in the ascites form 
were transferred to spinner culture. Analysis of PNA receptors ahowed 
that the level of ASGP-1 decreased with time in culture (Figure 8). 
Similar results were observed for :t:-1AT-B1 cells using either the PNA 
Figure 6. Guanidine HCl and CsCl Density Gradient Profile of 
amine Metabolically Labeled MAT-Bl Ascites Cells 
Solid Tumor Glycoproteins (B), ~iAT-MRl-S Ascites 
and MR Cells Cultured Attached to the Substratum 
[ 3 -HJGlucos-
(A), 13762 
Cells (C) 
(D). 
Centrifugation was performed as previously described (Sherblom, 
Buck and Carraway, 1980a). Abscissa: elution weight (g); 
Ordinate: (left) cpm, (right) density (g/ml). 
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Figure 7. Comparison of Labeling Profiles of MR Spinner Culture Cells 
(A) to 13762 Solid Tumor (B) by [125I]Concanavalin A 
Staining (Panel I) and [3H)Glucosamine Metabolic Labeling 
(Panel II). 
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Figure 8. [1 25 r1PNA Staining of Slab Gels of SDS-Solubilized HAT-HR1-S 
Ascites Cells (A), and MR1-S Cells Cultured in Spinner 
(McCoy's SA, Hodified, plus 10% Fetal Calf Serum) 1.8 Days 
(B), 7.8 Days (C) and 64 Days (D). Gel is a 4.5-15% 
acrylamide linear gradient slab. 
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receptor analysis (Figure 9) or glucosamine labeling (data not shown) to 
detect ASGP-1. 
Expression of ASGP-1 during Early Passages 
in Ascites Form 
The previous results indicate that expression of ASGP-1 as determined 
by glucosamine labeling or PNA receptor analysis is sensitive to the 
environment or growth state of the cells and suggest that ASGP-1 may be 
required for survival or growth in ascites form. For analysis of events 
occurring after transplantation, the MR cells were cloned. Several 
morphologi~ally different clones were selected and transplanted. PNA 
receptor analyses of early in vivo passages of MR cells and the clones 
(in the ascites forms) showed an increase in a slow migrating band with 
an apparent molecular weight greater than 150,000 daltons (Figure 10). 
It was not identical to ASGP-1, however, because its electrophoretic mobil-
ity was different. Moreover glucosamine labeling did not show enhancement 
of this band in the ascites cells (Figure 11). ASGP-1 did not arise in 
the ascites forms derived from MR cells or its clones until later passages, 
including both morphological effects (Figure 13, note increased microvilli) 
and glycoprotein changes. MAT-B1 cells show somewhat similar morphological 
changes (in reverse) when transferred to cell culture (Figure 13). More-
over, a broad band at about 150 K observed by PNA receptor analysis (Figure 
10) and glucosamine labeling (Figure 11) in the cultured cells is dimin-
ished or absent in the ascites cells. 
Discussion 
The present studies were undertaken to try to delineate some of the 
Figure 9. [125r]PNA Staining of Slab Gels of SDS-Solubilized B1 Cells in 
Spinner Culture (McCoy's SA, Modified plus 25% Fetal Calf 
Serum) 5.5 Hours (A), 24 Hours (B), 47 Hours (C), 95 Hours 
(D) and 166 Hours (E). Slab is a 4.5-15% acrylamide linear 
gradient. 
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Figure 10. e25 r]PNA Staining of Slab Gels of SDS-Solubilized MR Cells 
Maintained in Continuous Culture (A), the First Ascites 
Passage of the MR in F344 Rats (B), Clan~ 6 of MR in 
Culture (cMR6), Passage Number 4 (C), the First Ascites 
Passage of (C) in F344 Rats (D), Clone 9 of MR in Culture 
(cMR9), Passage Number 4 (E), the First Ascites Passage 
of (E) in F344 Rats (F), Clone 10 of HR in Culture 
(cMR10), Passage Number 4 (G), and the First Ascites 
Passage of (G) in F344 Rats (H). Electrophoreses were 
on 4.5-15% acrylamide gradient slabs. 
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Figure 11. Comparison of SDS-Polyacrylamide Gel Profiles of [ 3H]Glucos-
amine Metabolically Labeled Cells, HR Clone 6 (cMR6) 
Passage 4 In Vitro (A), the First Ascites Passage of (A) 
in F344 Rats (B), MR Clone 8 (cMR8) Passage 4 In _\Titro 
(C), the First Ascites Passage of (C) in F344 Rats (D), 
MR Clone 9 (cMR9) Passage 4 In Vitro (E), the First 
Ascites Passage of (E) in F344 Rats (F), MR Clone 10 
(cMR10) Passage 4 In Vitro (G), the First Asctites Passage 
of (G) in F344 Rats (H). Electrophorese~ were on a 
4.5-15% acrylamide linear gradient slab. Autoradiogram 
was exposed 34 days. 
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Figure 12. [ 125 r]PNA Staining of Polyacrylamide Gels of SDS-Solubilized 
MR Clone 6 (cMR6) in Culture, Passage 4 (A), and Maintained 
as an Ascites Tumor (MAT-CMR6) in F344 Female Rats (B-F): 
Passage 1 (B), Passage 4 (C), Passage 6 (D), Passage 15 (E) 
and Passage 20 (F). 
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Figure 13. Scanning Electron Micrographs of MR Clone 6 (cMR6) In Vitro 
(A), and the Third Ascites Passage of cMR6 in F34~Rats 
(B), MAT-B1 Ascites Cells (C), and B1 Spinner Culture 
Cells after Culturing 7 Days (D). A, Band Care 
3400 X and D is 3100 X magnification. 
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factors important in the expression of cell surface glycoproteins of 
13762 tumor cells. We have concentrated on the major sialoglycoprotein 
ASGP-1 of the 13762 rat mammary adenocarcinoma ascites cells for several 
reasons: 1) It is the predominant glycoprotein of these cells, .contain-
ing greater than 70% of the protein-bound label in cells metabolically 
labeled with glucosamine (Sherblom, Buck and Carraway, 1980a). 2) It is 
the only significant PNA receptor in the ascites cells, providing an 
additional specific assay (Sherblom, Buck and Carraway, 1980a). 3) It 
can also be identified by its position on CsCl density gradients in 4 M 
guanidine hydrochloride. 4) The glycoprotein has been recently purified 
(Sherblom, Buck and Carraway, 1980a) to homogeneity for further character-
ization and for antibody production. 5) ASGP-1 is not detected by the 
above techniques in either solid tumors (Huggins~ al., 1980a) or in a 
cultured form of the tumor derived from an ascites subline. 
This la~t result suggests that the presence of ASGP-1 might be 
required for ascites growth. That this is not the case was shown by the 
absence of ASGP-1 in early passages of the cultured tumor transplanted to 
give an ascites form. ASGP-1 did arise in later passages. Conversely, 
if the ascites tumor was transferred to culture or to a solid tumor by 
subcutaneous implantation, ASGP-1 disappeared over the period of several 
passages in the new form. Two likely explanations can be offered for this 
behavior: 1) The cells modulate their surface properties in response to 
some unknown stimulus or stimuli; or 2) the changes result from clonal 
selection of a population of the cells, and growth of cells without ASGP-1 
is favored in the solid and cultured forms of the tumor whereas growth of 
cells containing ASGP-1 is favored in the ascites form. Two observations 
favor the former interpretation: 1) The increase in ASGP-1 in the 
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ascites form does not appear to be a continuous process, but occurs 
somewhat abruptly at a later passage. Exactly what factors are involved 
is unclear. 2) The clones undergo early modifications similar to that 
observed for the tumor which has not been cloned. However, the length 
of time required for the change might allow genetic changes that could 
produce new forms which would undergo a positive selection (Fidler, 1978). 
The selection pressure required for loss of ASGP-1 is unknown. An 
understanding of the mechanism of cellular change would be facilitated 
by knowledge of the molecular changes. Loss of ASGP-1, as detected by 
PNA assay, glucosamine labeling and density gradient centrifugation, 
requires e~ther the failure to synthesize the polypeptide of ASGP-1 or 
a major alteration in the carbohydrate content of the glycoprotein. 
Using antibody prepared against the polypeptide chain portion of ASGP-1, 
it should be possible to distinguish between these possibilities. 
Somewhat similar behavior has been observed for the TA3 mammary 
adenocarcinoma. The major sialoglycoprotein disappears on transfer to 
cell culture (Cooper et al., 1977). There is also a decrease in the 
sialoglycoprotein upon subcutaneous transplantation to give a solid 
tumor. Hm.;rever, in contrast to results with the 13762 tumor, the 
sialoglycoprotein increases with increased passage in the solid form 
until it approximates the level in the ascites form. Cooper et al. 
(1977) have suggested that the sialoglycoproteins of the TA3 tumor may 
contribute to the metastatic potential of these cells. The clones 
derived from the 13762 MR tumor should provide a system for testing the 
relationship between metastasis and the expression of ASGP-1. 
CHAPTER III 
CHARACTERIZATION OF TWO NEW 13762 
VARIANT ASCITES SUBLINES 
Introduction 
At least five 13762 rat mammary adenocarcinoma sublines (MAT-A, 
MAT-E, ~AT-Bl, MAT-C, MAT-Cl) have been previously described (Carraway 
et al., 1978; Sherblom et al., 1980c; Sherblom, Buck and Carraway, 1980a). 
These five sublines (Figure 14) differ in surface morphology, Con A 
receptor redistribution, xenotransplantation and sugar composition of the 
oligosaccharide chains attached to the major cell surface glycoprotein, 
ASGP-1. The MAT-C and MAT-Cl cells have branched microvilli, no observa-
ble long-range lectin receptor redistribution and are transplantable 
across species barriers into mice. These sublines also contain large 
amounts of sialic acid and very little sulfate (Sherblom and Carraway, 
198Gb). In contrast, the MAT-E and MAT-Bl sublines have more normal-
appearing non-branched microvilli, lectin receptor redistribution and are 
not transplantable across species barriers. These sublines contain 
approximately one-third as much sialic acid as the MAT-Cl line (Sherblom, 
B k d C 1980 ) d . . 'f' of r35 s~so42-uc an arraway, a an 1ncorporate s1gn1 1cant amounts L ;~ 
into the glycoprotein ASGP-1. The MAT-A cells are similar to the MAT-E 
cells (Sherblom et al., 1980c; Carraway~ al., 1978; Sherblom and 
Carraway, 1980b). 
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Figure 14. Schematic Diagram Showing the History of the 13762 Rat 
Mammary Adenocarcinoma Sublines. 
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Evidence is presented in Chapter II showing that when the 13762 
cell culture line (13762 MR) is transplanted into F344 female rats, the 
sialoglycoprotein ASGP-1 develops after at least 16 passages. Two 
_ascites tumor lines containing ASGP-1 were obtained in this manner and 
55 
have been further characterized. The MAT-cMR6-S cells were derived from 
a recently cloned 13762 MR linewhereas the MAT-MR2-S cells were derived 
from the MR 13762 cells maintained in continuous culture for approxi-
mately three years followed by one freeze-thaw. These new ascites lines 
differ from the previously described 13762 rat mammary adenocarcinoma 
variant ascites sublines. 
Materials 
D-1-(3H]glucosamine HCl (2-6 Ci/mmole) and L35s]sulfate (100 mCi/ 
mmole) were from Amersham; Instagel was from Packard; CsCl (99.99%) was 
a product of Varlacoid; guanidine hydrochloride (Grade I) was from Sigma. 
Ascites cells were maintained as previously described (Sherblom, 
Buck and Carraway, 1980a). 
Methods 
FITC-Con A lectin receptor redistribution, D-1-[3H]glucosamine and 
[35 s]so4 2~ incorporation in vivo, ASGP-1 purification and isopycnic 
density gradient centrifugation in CsCl with 4 M guanidine hydrochroride 
alkaline borohydride hydrolysis and Biogel P4 chromatography were 
performed as previously described (Huggins et al., 1980b; Sherblom, Buck 
and Carraway, 1980a). Sialic acid release and assay were performed as 
described by Buck (1978). Scanning electron microscopy was performed 
as described by Carraway et al. (1979). 
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Xenotransplantation 
For each tumor line tested, eight C57Bl/6J female mice were 
6 injected with 1 x 10 tumor cells suspended in 0.25 ml of 0.9% saline, 
pH 7.4. Contiols were injected with 0.25 ml saline. 
Results 
As shown in Figure 15, there are distinct mqrphological differences 
between early ascites passages (B,E) of the tumor cells compared to the 
cells maintained in culture (A,D). The cultured cells have an abundance 
of ruffles with no distinct microvilli. Blebbing occurs whether the cells 
are grown attached to a substratum or in spinner culture. The most 
prominent morphological alteration during early ascites passages (B,E) 
is the development of distinct cell surface microvilli. This represents 
an increase in the total membrane area exposed to the environment. 
However, in one case a much more pronounced morphological alteration is 
observed concommitant with or shortly after development of the large 
sialoglycoprotein ASGP-1 (C). BetvJeen the fifteenth and twenty-second 
passages, the MAT-cMR6-S microvilli developed a branched structure(C), 
similar to that observed in electron micrographs of the MAT-C1 cells 
(Carraway et al., 1978). Once again the total cell surface area has 
been increased. The MAT-MR2-S microvilli (F), although not branched, 
appear either as single structures or as clumps of microvilli attached 
to each other at the t.ips. 
From previous studies on the MAT-C1 and MAT-B1 cells, the MAT-C1 
Con A lectin receptor redistribution is greatly restricted whereas the 
MAT-B1 Con A receptors redistribute freely. Neither the MAT-cMR6-S 
Figure 15. Scanning Electron Micrographs Showing the Progressive 
Morphological Changes as Cultured Cells Adapt to Ascites 
Growth. (A) cMR6 (MR clone 6) in in vitro culture, 
passage 4, (B) MAT-cMR6, ascites passage 3, (C) MAT-cMR6-S, 
ascites passage 22, after development of ASGP-1, (D) MR in 
in vitro culture attached to substratum, (E) MAT-MR2 ascites 
passage 13 and (F) MAT-MR2-S, ascites passage 28, after 
development of the glycoprotein. Magnification: A,B,D,E, 
3400; C,F, 3100. 
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cells nor the MAT-MR2-S cells (Figure 16) show the large-scale Con A 
lectin receptor residtribution observed for MAT-B1 cells (Carraway et 
al., 1978). Nevertheless, minor lectin receptor mobility is apparent. 
It has previously been suggested that the xenotransplantability 
difference observed between the MAT-B1 and ·r:.rAT-Cl cells could be due to 
the differences observed in the oligosaccharide composition of ASGP-1 
isolated from these sublines (Sherblom, Buck and Carraway, 1980a). 
Therefore, the ASGP-1 isolated from the MAT~c:t:1R6-S and 1-1AT-MR2-S ascites 
sublines was partially characterized in order to substantiate further 
or disprove this theory. Figure 17 shows that MAT-cMR6-S ASGP-1 migrates 
with a density of 1. 401 in Csl:::l and 4 M guanidine hydrochloride and can 
be labeled using [ 3H]glucosamine and [ 35s]sulfate. Both of these 
properties have also been observed for the MAT-B1 ASGP-1. On the other 
hand, MAT~MR2-S ASGP-1 (Figure 18) has an apparent density of 1.410 and 
incorporates eH]glucosamine but scant, if any [ 35s]sulfate. These 
properties are similar to MAT-C1 ASGP-1 (Sherblom, Buck and Carraway, 
1980a). 
As statedpreviously, the sugar composition of the MAT-B1 ASGP-1 
oligosaccharide side chains differs from 1-1AT-C1. Following ASGP-1 
purification, the 0-linked oligosaccharide side chains are released from 
the protein core using mild alkaline-borohydride hydrolysis. Chromatogra-
phy over Biogel P4 separates the released oligosaccharide side chains 
according to size. Two major oligosaccharide peaks are observed for 
MAT-C1 ASGP-1 labeled in vivo with [ 3H]glucosamine and three for MAT-Bl 
---
ASGP-1 (Sherblom, Buck and Carraway, 1980a). The Biogel P4 profile 
(Figure 19A) of the oligosaccharides released from [ 3H]glucosamine 
labeled MAT-cMR6-S ASGP-1 provides further evidence that the MAT-cMR6-S 
Figure 16. Dark-Field Micrographs of FITC-Con A Labeled Prefixed 
MAT-cMR6-S Cells Passage 25 (A), MAT-cMR6-S Cells Treated 
with 1 mg/ml FITC-Con A in DPBS with 1 mg/ml Glucose, pH 
7.4 30 min at 37° Followed by Fixation in 1% Glutaraldehyde 
(B), MAT-MR2-S Passage 22 Prefixed Cells (C) and MAT-MR2-S 
Cells Treated with FITC-Con A before Fixation. 
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Figure 17. Isopycnic Centrifugation of [ 3H]Glucosamine (()) and 
[ 35s]so42- ( •) Labeled MAT-cMR6-S Membrane Vesicles in 
CsCl Gradients Containing 4 M Gdn HCl CQ). 
63 
32 
1.50 
1'0 b2: 
X 1.40 
~ 
0.. 
0 
,------, 
I 
1.30 1'0 L--.1 0 
m 
z 
(j) 
-1 
-< 
1.50 ill. 
" C\1 0 I 0 0 
X 
~ 1.40 
0.. 
0 
.---, 
(f) 
lO 
1'0 1.30 L---1 
5 10 15 
ELUTION WEIGHT (gJ 
Figure 18. Isopycnic Centrifugation of ( 3H]Glucosamine (()) and 
[35s]so42- ( •) Labeled MAT-MR2-S Membrane Vesicles in 
CsCl Gradients Containing 4 M Gdn HCl <0). 
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Figure 19. Gel Filtration of MAT-cMR6-S (A) and MAT-MR2-S (B) ASGP-1 
Products on Biogel P4 Following Alkaline-Borohydride 
Treatment (1.0 M NaBH4, 0.05 M NaOH, 16 hours, 450), The 
samples were mixed, alkaline-borohydride treated, neutra-
lized with acetic acid and chromatographed on a Biogel 
P4 column (200-400 mesh, 0.9 x 113 em) equilibrated with 
1.0 M pyridine-acetate, pH 6.0. Fractions were assayed for 
determination of 3H (0) and 35s <•) radioactivity. 
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ASGP-1 is very similar to MAT-B1 ASGP-1 (Sherblom, Buck and Carraway, 
1980a). However, the oligosaccharide composition of the MAT-HR2-S 
ASGP-1 (Figure 19B) is even simpler than that observed for MAT-C1 ASGP-1. 
Only one major oligosaccharide peak is observed. 
Although the specific sugar composition of the oligosaccharide 
side chains has not been determined, acid hydrolysis releases only 
slightly less sialic acid from MAT-MR2-S cells than from MAT-C1 cells. 
Once again, comparable amounts of sialic acid are released from both 
MAT-cMR6-S and MAT-B1 cells (Table I). 
During a xenotransplantation study of the MAT-cMR6-S and MAT-MR2-S 
cells into C57BL/6J mice, 6 of 8 mice injected with 1 x 106 ~1AT-cMR6-S 
cells died due to ascites tumors within 30 days. At the end of 90 days 
none of the mice injected with MAT-MR2-S ascites cells, the 13762 MR cell 
culture cells or the saline controls had died. 
Thus, the ¥.AT-cMR6-S cells exhibit a surface morphology similar 
to the MAT-C1 cells, have a degree of Con A lectin receptor redistribution 
intermediate between Y~T-C1 and MAT-B1 cells and are xenotransplantable. 
However, l1AT-cMR6-S ASGP-1 resembles }fAT-B1 ASGP-1 in density, chromato-
[ 35] graphic profile of the oligosaccharides, S sulfate incorporation and 
acid hydrolyzable sialic acid. 
In contrast, MAT-MR2-S cells have a surface morphology more like 
the MAT-B1 cells, although some of the MAT-MR2-S microvilli appear to be 
agglutinated or cross-linked at the tips. The l1AT-MR2-S cells show much 
less Con A lectin receptor redistribution than MAT-B1 cells and are not 
xenotransplantable under the conditions used. However, ~~T-MR2-S ASGP-1 
exhibits a density and sialic acid composition similar to MAT-C1 ASGP-1. 
MAT-HR2-S ASGP-1 does differ appreciably from MAT-C1 ASGP-1 with respect 
TABLE I 
SUMMARY OF PROPERTIES OF MAT-MR2-S, MAT-cMR6-S, 
MAT-B1 AND 1-'IAT-G1 ASCITES 13762 RAT 
MAJ~Y ADENOCARCINOMAS 
Property ~.AT-MR2-S MAT-clffi6-S MAT-B1 
[125 I]PNA Binding (+) (+++) (+++) 
Sulfation (+,-) (+) (+) 
Morphology of 
Microvilli Not Branched Branched Not Branched 
[125 ] I Con A Receptor 
Redistribution (-) (+,-) (+) 
nmoles Sialic Acid 
Per 1 x 107 Cells 28 13 16 
ASGP-1 Density 1.41 1.40 1.40 
Number of Major ASGP-1 
Oligo saccharides 1 3 3 
Xenotransplantation (-) (+) (-) 
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MAT-C1 
(++) 
(-) 
Branched 
(-) 
37 
1.41 
2 
(+) 
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to the oligosaccharide profile observed on Biogel P4. 
Discussion 
The results summarized above indicate that the xenotransplantation 
difference Carraway ~ al. have observed between the MAT-B1 and MAT-C1 
ascites cells (Carraway et al., 1978; Sherblom; Buck and Carraway, 1980a) 
cannot be attributed solely to the variation observed in the ASGP-1 
oligosaccharides since the MA.T-cHR6-S cells have a surface morphology 
similar to the MAT-C1 cells by scanning electron microscopy, an ASGP-1 
very similar to MAT-B1 ASGP-1 and are xenotransplantable. 
However, it is possible that the microvillar structure is a critical 
factor in determining xenotransplantability. Since ASGP-1 is a major 
component of the microvilli (Howard et al., submitted for publication), 
ASGP-1 may be one determinant of the microvillar structure. Nevertheless, 
the microvilli are comprised of a number of proteins as well as membrane 
lipids. Alteration or absence of any critical microvillar structural 
component could alter the microvillar morphology observed. Thus, the 
MAT-B1 cells could lack a different microvillar structural component 
critical for formation of branched microvilli. 
CHAPTER IV 
RELEASE OF CELL SURFACE MATERIAL FROM MAT-B1 
AND MAT-C1 ASCITES RAT HAMMA.l\.Y 
ADENOCARCINOMA CELLS 
Introduction 
Cell surface glycoproteins are believed to play important roles in 
allowing the escape of tumor cells from destruction by the immune system 
of the host (Nicolson and Paste, 1976). It has been postulated that the 
shedding of cell surface antigens and other glycoproteins from the 
tumor may block destruction of the tumor cells by cells of the immune 
system (Nicolson and Paste, 1976; Hellstrom and Hellstrom, 1974; Cooper, 
Codington and Brown, 1974; Kim~ al., 1975), but as yet there is rela-
tively little information concerning the mechanisms by which cell surface 
material is shed. Miller et a1.(1978a,b) have investigated the kinetics 
of release of glucosamine-labeled, perchloric acid-soluble components 
from the cell surface of the allo- and xenotransplantable mouse ascites 
.Ta3-Ha mammary adenocarcinoma. Vicia graminea receptors derived from 
the major cell surface sialoglycoprotein(s) epiglycanin were released in 
a biphasic manner. Hov7ever, several questions remain unanswered concern-
ing the mechanisms of release of cell surface components. Since the 
native form(s) of epiglycanin was (were) not characterized, it is not 
possible to compare the released and cell-associated forms of the 
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glycoprotein. The fact that the released material is soluble suggests 
an alteration in the glycoprotein is occurring with the release. More-
over, such analyses ignore possible contributions of shed, insoluble 
fractions. Shedding of membrane fragments has been observed with mammary 
carcinomas (Nordquist, Anglin and Lerner, 1977) and other cells (Van 
Blitterswijk et al., 1977) and may be an intermediate in the release of 
soluble surface material. 
For our investigations of these questions we have used the MAT-B1 
and MAT-C1 ascites sublines of the 13762 rat mammary adenocarcinoma. 
These are similar to the St and Ha sublines of the TA3 adenocarcinoma 
in many respects, but offer several advantages. Although the MAT-C1 
subline is xenotransplantable and MAT-B1 is not, both have large amounts 
of a single major cell surface sialoglycoprotein termed ASGP-1 (Buck, 
Sherblom and Carraway, 1979; Sherblom et al., 1980c; Sherblom, Buck and 
Carraway, 1980a). This contrasts with the TA3 sublines in which the 
allo- and xenotransplantable Ha subline has epiglycanin, but the 
nontransplantable St subline does not (Codington et al., 1975; Miller, 
Hay and Codington, 1977). Moreover, the ASGP-1 from both MAT-B1 
and MAT-C1 sublines has been purified to homogeneity and shown to be the 
same size as the glycoprotein solubilized directly in SDS from the 
corresponding cells (Sherblom, Buck and Carraway, 1980a). Amino acid 
compositions from MAT-B1 and MAT-C1 were very similar, but their 
carbohydrate compositions, molecular weights and oligosaccharides were 
different (Sherblom, Buck and Carraway, 1980a). During in vivo or in 
vitro metabolic labeling each subline incorporates greater than 70% of 
protein-bound glucosamine label into ASGP-1 (Sherblom et al., 1980c; 
Sherblom, Buck and Carraway, 1980a). Finally, previous studies have 
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demonstrated the release of particulate cell surface fractions, including 
microvilli (Huggins et al., 1980b), from these cells, and procedures 
have been developed for fractionating these materials (Carraway et al., 
1980; Huggins et al., 1980b). 
The current studies set out to answer the following questions. 
What are the differences between the shed soluble and native membrane-
bound forms of ASGP-1 that might relate to the mechanism of shedding? 
What is the nature of the particulate material shed in vitro and in vivo? 
What are the rates of shedding of soluble and particulate fractions for 
the two sublines? How do the amounts and types of materials shed from 
the two sublines compare? Using the metabolic labeling and fractionation 
of released cellular components on Percoll gradients or by differential 
centrifugation we have found that ASGP-1 is released on microvilli or 
membrane fragments and in soluble form. The soluble form, after denatura-
tion in dodecyl sulfate, appears smaller by gel filtration than purified 
ASGP-1 or ASGP-1 from shed microvilli (Howard et al., submitted for publi-
cation), suggesting that proteolysis may be involved in its release. 
Release of the soluble ASGP-1 is decreased by the protease inhibitor Apro-
tinin or EDTA, providing further evidence for a proteolytic cleavage 
mechanism of release. Examination of ascites fluid showed similar types 
of shed material to those found in vitro. The rates of release of cell 
surface material in vitro were similar for MAT-Cl and MAT-Bl cells. The 
amount of soluble ASGP-1 in ascites fluid was 2.5 times greater for MAT-C1 
than MAT-B1 cells, but the amount of ASGP-1 in the ascites fluid in insol-
uble form was slightly less for MAT-C1 than MAT-B1 cells. Although the 
increased amount of soluble ascites fluid ASGP-1 for MAT-C1 cells corre-
lates with the xenotransplantability, it is doubtful whether this 
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quantitative difference in shedding can be responsible for the transplan-
tation differences. 
Materials 
McCoy's SA (modified), nonessential amino acids, fetal calf serum, 
EDTA and penicillin/streptomycin solution were from Gibco, sodium pyruvate 
was from.Microbiological Associates, PPO (2,5-diphenyloxazole), soybean 
trypsin inhibitor, trypsin, actinomycin D, cycloheximide, puromycin, 
colchicine, cytochalasin D, theophylline, sodium azide, 2-deoxyglucose, 
PMSF (phenylmethyl sulfonyl fluoride), Aprotinin and EGTA were from Sigma, 
D-1-[3H]glucosamine HCl (2-6 Ci/mmole), [ 3H]leucine (55 Ci/mmole) and 
carrier-free [ 125r]Nal were from Amersham/Searle. Instagel was from 
Packard, Percell was from Pharmacia, polycarbonate filters were from Bio-
Rad, peanut lectin was from Miles-Yeda, Ltd. and calcium ionophore A23187 
was a gift from Eli Lilly. 
The 13762 ascites tumors (Carrmvay ~ al., 1978) were passaged as 
described previously (Sherblom et al., 1980c). 
Methods 
Characterization of Shedding In Vitro 
MAT-B1 or MAT-C1 tumor-bearing. rats were injected with 0.1 mCi 
[ 3H]glucosamine 16-17 hours before sacrifice (Sherblom et al., 1980c; 
Sherblom, Buck and Carraway, 1980a). Tumor cells were removed aseptically 
and washed three times with McCoy's SA (modified) culture medium to which 
25% fetal calf serum and 10 pg/ml Gentamicin had been added. Cells were 
resuspended in fresh medium with fetal calf serum and incubated in spinner 
culture at 37° in a 5% co2 atmosphere for various times. For pulse-chase 
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analysis of the kinetics of shedding the incubations contained 3.8 x 10-3 
pmole/ml cold gulcosamine. Insoluble fractions were separated from cells 
using a 30% Percell self-forming gradient. Soluble ASGP-1 was obtained 
after pelleting cells at 121 g for 15 min by filtering through 0.1 p 
pore size polycarbonate membranes followed by dialysis against water or 
by centrifuging at 100,000 g for 1.5 hours. 
Radioactive fractions were coupted in 10 ml Instagel in a Tri-Carb 
liquid scintillatioh counter. Electrophoresis in SDS on 4.5~15% gradient 
polyacrylamide gels was performed as previously described (Sherblom, Buck 
and Carraway, 1980a). 
Trypsin Treatment of MAT-B1 Cells 
Labeled, washed MAT-B1 cells, obtained as described above, were 
resuspended in complete medium with 1 mg/ml glucose, then treated with 
50 pg/ml trypsin for 30 min in DPBS. Soybean trypsin inhibitor was added 
(100 pg/ml) for an additional 30 min, and the cells were washed and used 
for a shedding experiment. 
Effect of Perturbants on In Vitro Shedding 
Experiments were performed as described above, using a two hour incu-
bation, except that the effectors were included at the concentrations 
noted. Effectors (and concentrations) used were: soybean trypsin inhibi-
tor (1 mM), phenylmethyl sulfonyl fluoride (1 mM), colchicine (1 mM), EGTA 
(1 ~1), ionophore A23187 (0.5 mM) with and without 1 mM CaC12 , theophylline 
(1 mM), cytochalasin D (1 mM), sodium azide (1 mM), actinomycin D (0.1 ~~), 
puromycin (0.1 mM), cycloheximide (1 mM), Aprotinin (20 Kiu/ml), EDTA 
(1 mM), deoxyglucose (1 mM) and dibucaine (1 mM). 
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Characterization of Material Shed In Vivo 
The labeled cell suspension was aspirated from the rat peritoneal 
cavity without dilution and cells were pelleted at 480 g for 5 min. 
Particulate and soluble fractions were obtained by Percell gradient and 
differential centrifugation, respectively, as described above. Protein 
was quantitated by the method of Lowry et al. (1951). Other characteriza-
tion procedures were performed as described above. 
Incorporation of [ 3H]Leucine 
Ascites cells were removed aseptically from the peritoneal cavity of 
MAT-B1 and MAT-C1 tumor-bearing F344 female rats. Cells were washed two 
times using McCoy's SA (modified) media, pelleted at low speed in a 
clinical centrifuge, then resuspended at approximately 6-7 x 106 cells 
per ml in media supplemented with 25% fetal calf serum and 10 pg/ml 
Gentamicin antibiotic. Spinner cultures were grown in a 5% C02 atmosphere 
for the remainder of the experiment. [ 3H]leucine (6.7 pCi/ml) was 
injected and sampling begun. At each time point, three 0.1 ml aliquots 
were heat denatured onto GF/A glass fiber filters, soaked in 10% TCA, 
washed using 5% TCA followed by ice cold water, solubilized in 0.5 ml 
Soluene 350 and counted for radioactivity using 10 ml Instagel solvent. 
At the same time, a 1.0 ml aliquot of the cell suspension was diluted to 
5 mls with a Percoll-DPBS mixture giving a final Percell concentration 
of 8% for MAT-B1 cells and 11% for MAT-C1 cells. Cells were pelleted at 
2000 rpm for 5 min, then solubilized in electrophoresis sample buffer 
. 0 5 
containing 3% SDS and mercaptoethanol at 100 10 min. 1.5 x 10 cells 
per well were electrophoresed on a 4.5-15% acrylamide gradient slab. The 
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ASGP-1 and actin bands were sliced out using a razor blade, solubilized 
in 0.3 ml Soluene 350 and counted for radioactivity using 5 ml Instagel 
solvent. 
Quantitation of Soluble ASGP-1 in Ascites Fluid 
ASGP-1 was purified from MAT-B1 and MAT-Cl cells as previously 
described (Sherblom, Buck and Carraway, 1980a). Various amounts of the 
glycoproteins (0.02~1.5 pg) 'tvere applied to 4.5-15% gradient polyacryl-
amide gels and electrophoresed in SDS. The gels were reacted with 125r-
labeled peanut agglutinin, which reacts specifically with ASGP-1 (Huggins 
et al., 1980a). The labeled glycoprotein-lectin bands were cut from the 
gels and counted to prepare a standard curve, which was linear for each 
glycoprotein over the range of protein concentrations used. Samples of 
the soluble fraction of ascites fluid were subjected to the same procedure, 
permitting determination of the concentrations of ASGP-1 in each ascites 
fluid sample. 
Results 
Characterization of Shedding In Vitro 
For characterization of the shed material, glycoproteins of MAT-B1 
and }'f.AT-Cl cells were label·ed by injection of [ 3H]glucosamine into the 
peritoneal cavity. As shown previously (Buck, Sherblom and Carraway, 
1979; Sherblom, Buck and Carraway, 1980a; Sherblom et al., 1980c), the 
protein-bound label is found predominantly in one component, ASGP-1, 
illustrated .in Figures 20 and 21 for MAT-B1 and MAT-Cl cells, respectively. 
Several experiments indicate that this component is at the cell surface 
in both sublines: 1) It is labeled by 1251 and lactoperoxidase 
Figure 20. Polyacrylamide Gel Electrophoresis in SDS of [ 3H]Glucosamine 
Labeled MAT-Bl Cells (A,D), Particulate Shed Fraction 
(B,E) and Soluble Shed Fraction (C,F). Gels A-C were 
stained with Coomassie blue and D-F are fluorograms 
showing the radioactive components .. Note the predominance 
of ASGP-1 in all labeled fractions. 
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. ABCDEF 
Figure 21. SDS Polyacrylamide Electrophoresis of [ 3H]Glucosamine 
Labeled MAT-Cl Cells (A,E), Shed Microvilli Fraction 
(B,F), Shed Membrane Fragment and Vesicle Fraction (C,G) 
and Shed Soluble Material (D,H). Cbriditions are as in 
Figure 20. 
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(Sherblom ~ al., 1980c). 2) Glucosamine label can be released by 
trypsin or chymotrypsin from the cells (Buck, Sherblom and Carraway, 
1979). When cells are treated with Pronase, most of the ASGP-1, assayed 
by SDS polyacrylamide gel electrophoresis and autoradiography, is degrad-
ed before the permeability barrier of the cells is broken (Huggins et al., 
1980b). 3) ASGP-1 co-isolates with 5'-nucleotidase on putative plasma 
++ 
membrane fractions obtained from a microsome preparation or from a Zn 
s~abilized membrane preparation (Sherblom, Buck and Carraway, 1980a). 
When cells are incubated in vitro, released cell surface material 
can be observed by dark field microscopy or by fluorescence microscopy 
after staining with fluorescent Con A. MAT-Cl microvilli were identified 
by the unusual morphology of the branched microvilli (Huggins et al., 
1980b). The presence of ASGP-1 in these shed fractions was ascertained 
in prelabeled cells by low speed centrifugation to remove the cells and 
quantitation of the radioactivity in the supernatant. SDS polyacrylamide 
gel electrophoresis of the supernatants confirmed the presence of ASGP-1. 
However, differential centrifugation did not adequately separate cells 
from the shed insoluble material. Therefore Percoll gradient centrifuga-
tion was used (Huggins~ al., 1980b). Three fractions are obtained from 
a Percoll gradient for MAT-C1 cells; two are found for MAT-Bl cells. By 
microscopy these were identified as 1) microvilli, 2) membrane fragments 
or vesicles and 3) cells. The middle fraction is absent for MAT-Bl cells. 
Although the three fractions can be obtained in pure form from a carefully 
controlled gradient, the microvilli and fragment fractions tend to overlap 
somewhat. Figure 22 shows a typical Percoll gradient profile for shed 
material from MAT-C1 cells in which fractions 5 and 6 contain predominant-
ly fragments and 2-4 contain predominately microvilli. For the results 
Figure 22. Percoll Gradient Profile of MAT-Cl Cells (Major Peak) and 
Particulate Fraction (Smaller Peak) Shed In Vitro. Gradient 
was run as previously described (Huggins et al., 1980b). 
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presented in this work we have considered the insoluble, shed fractions 
together for quantitative analysis. The soluble fraction of shed materi-
al was obtained by centrifugation at 100,000 x g tor one hr. The shed, 
particulate material is quite heterogeneous in size (Howard et al., sub~ 
mitted for publication). Dark field microscopy indicates that microvilli 
predominate in the heavier fractions. 
Examination of the labeled shed material by SDS polyacrylamide 
electrophoresis and fluorography showed ASGP-1 to be the only significant 
labeled component in the soluble fractions (Figures 20 and 21). Micro-
villi and the fragment (vesicle) fraction also contain predominately 
ASGP-1, although a small amount of a second labeled component (ASGP-2) was 
present but not readily discernible in the photographs of Figures 20 and 
21. 
To show that the soluble ASGP-1 could have been released from the 
cell surface rather than secreted from within the cell, labeled MAT-B1 
cells were treated with trypsin, which cleaves cell surface ASGP-1 (Buck, 
Sherblom and Carraway, 1979). After incubation with trypsin inhibitor 
the cell suspension was washed to remove protease and incubated in medium 
for two hr. Released, soluble ASGP-1 was obtained after centrifugation. 
Electrophoresis and fluorography indicated that essentially all of the 
released ASGP-1 from the trypsin treated cells had been cleaved (Figure 
23), indicating that it had come from the cell surface rather than from 
within the cell. 
Kinetics of Shedding Processes 
To investigate the release process, MAT-B1 and MAT-Cl cells were 
labeled in vivo, transferred to culture and incubated in the presence of 
Figure 23. 
. 3 
Release of Soluble ASGP-1 from [ H]Glucosamine Labeled MAT-B1 
Cells With and Without Trypsin Pretreatment. Electrophoresed 
whole cells are shown in (A), isolated microvilli in (B), 
soluble ASGP-1 released from MAT-B1 cells without trypsin 
pretreatment (C) and soluble ASGP-1 released after trypsin 
pretreatment (D). The corresponding fluorogram is shown 
in wells E-H in the same order. 
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cold glucosamine. Aliquots were removed at intervals and fractionated 
to give cells, particulate shed material and soluble shed material. 
Release of both particulate and soluble material was linear for at least 
·eight hours in both MAT-B1 and MAT-Cl (Figure 24). Since there was no 
lag in the release of soluble material, ASGP-1 appears to be released 
directly from the cells rather than requiring further degradation of 
released microvilli or membrane fragments, although a slmv release of 
particulate material followed by rapid release of the soluble glycoprotein 
from its membrane would give the same result. The rates of shedding, 
based on the slopes of the lines, are quite similar for the two sublines 
for both soluble and particulate material. 
Loss of label from the cells follows a first order relationship 
(Figure 25) with half-lives of 4.1 + 0.5 da and 2.4 + 0.2 da (3 experi-
ments each) for MAT-B1 and MAT-C1 cells, respectively. Since the rate of 
turnover of label is greater than loss by shedding and is different 
between MAT-B1 and MAT-C1 cells, it is clear that turnover is more complex 
than shedding. Other processes must be involved to account for the turn-
over. Figure 26 shows that, using [ 3H]leucine incorporation, MAT-B1 
cells have a slower rate of synthesis of ASGP-1 than MAT-C1 cells although 
both cell lines exhibit similar levels of synthesis of total proteip and 
actin. 
Perturbation of the Shedding Processes 
by Effectors 
Since ASGP-1 is the predominant component of the surface of 13762 
ascites cells, the mechanism by which it is shed is of interest. Cellular 
ASGP-1 is membrane-bound, although it can be released from the membranes 
Figure 24. Release of Soluble (.&,D.) and Particulate ( 8, 0) Fractions 
from MAT-Bl (.&,e) and MAT-Cl (A, 0) Cells Incubated In 
Vitro. Ascites cells were labeled with [3H]Glucosamine-.-
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Figure 25. Loss of [ 3H]Glucosamine Labeled Material from MAT-Bl (A) 
and MAT-Cl (()) Cells. 
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Figure 26. Incorporation of [ 3H]Leucine into MAT-Cl ( 8, .A, •) and 
MAT-Bl (0, t::., D) TeA-Precipitable Proteins (e, 0), 
Whole Cell ASGP-1 (.A,!::.) and· Whole Cell Actin ( •, 0) 
in In Vitro Short-Term Culture with 6.7 pCi/ml and 
Cel~Densities 6-7 x 106 Cells/mi. 
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with guanidine hydrochloride (Sherblom, Buck and Carraway, 1980a) or 
nonionic detergent (Buck, Sherblom and Carraway, 1979). The fact that 
part of the shed ASGP-1 is soluble indicates that it must be altered in 
the shedding process. No change in apparent molecular size is observed 
by polyacrylamide gel electrophoresis. However, the negative charges 
and anomalous detergent binding characteristics of sialoglycoproteins 
make SDS polyacrylamide gel electrophoresis procedures unreliable for 
evaluating molecular.sizes and size changes. Coworkers have compared the 
gel filtration in SDS profiles of ASGP-1 from the shed fractions and 
ASGP-1 purified from plasma membranes (Howard~ al., submitted for 
publication; Sherblom, Buck and CarraHay, 1980a). They have found ASGP-1 
of the soluble fraction to be significantly smaller than purified ASGP-1, 
suggesting a cleavage mechanism of release. 
As a further characterization of the mechanisms of the shedding 
processes, a number of effectors were tested for their ability to inhibit 
or accelerate release of soluble ASGP-1 or particulate surface material. 
Only Aprotinin and EDTA, of the effectors tested, were able to inhibit 
release of soluble ASGP-1 and each caused a 30-35% inhibition. None of 
the effectors gave a consistent, significant inhibition of release of the 
insoluble fraction. Shedding of both soluble and particulate fractions 
was enhanced by dibucaine (soluble 1.7-fold; particulate, 2.4-fold) and 
ionophore A 23187'in the presence of calcium (soluble, 2.7-fold; particu-
late, 3.5-fold). The effects on the release of soluble ASGP-1 provide 
further support for a proteolytic mechanism, possibly involving a cation-
dependent protease. The effects of dibucaine and ionophore suggest a 
++ 
role for Ca . 
Shed Materials in Ascites Fluid of Animals 
Bearing MAT-B1 and MAT-C1 Tumors 
96 
To determine whether similar shedding processes occur in vivo, 
ascites cells and fluid were removed from animals injected with 
[3H]glucosamine. Immediate fractionation of the material on Percoll 
gradients gave results similar to those found for in vitro shedding with 
a broad peak at the density of the insoluble material. High speed 
centrifugation of labeled ascites fluid gave a soluble fraction which by 
SDS polyacrylamide gel electrophoresis (not shown) contained ASGP-1 as 
the only detectable labeled component. ASGP-1 was also the predominant 
labeled component of the particulate fraction isolated by Percell gradient 
centrifugation (Howard et al., submitted for publication). 
Consistent with their results from in vitro shedding, coworkers 
have shown that soluble ASGP-1 from MAT-C1 cells is smaller than the 
corresponding purified ASGP-1 using gel filtration in SDS and CsCl density 
gradient centrifugation. ASGP-1 from the particulate fraction isolated 
from ascites fluid is approximately the same size as purified ASGP-1 from 
MAT-C1 cells. Similar results were obtained for MAT-B1 cells (Howard et 
al., submitted for publication). 
Dark-field microscopy showed only membrane fragments and vesicles 
from the ascites fluid of both MAT-B1 and MAT-C1 cells, indicating that 
any intact microvilli shed from the cell surfaces must be degraded in 
the animal. Scanning electron microscopy of cell-free, glutaraldehyde-
fixed samples of ascites fluid showed stringy aggregates of cell surface 
material (not shown). No significant differences were observed between 
samples from MAT-B1 and MAT-C1 tumors. 
97 
The amounts of particulate shed material and soluble shed ASGP-1 
in ascites fluid were quantitated by protein analysis and the radio-
chemical lectin assay shown in Figure 27, respectively. The particulate 
fraction represented 0.8% and 0.6% of the total ascites fluid protein 
for ¥~T-B1 and MAT-Cl cells, respectively. Soluble ASGP-1 protein was 
0.12% of the total ascites protein for ~~T-B1 cells and 0.29% for ~~T-C1 
cells. Thus there is about 2.5 times as much soluble ASGP-1 in MAT-C1 
ascites fluid as in MAT-B1, but about equal amounts of particulate 
fraction in the two sublines. 
Discussion 
Since shedding of cell surface glycoproteins such as ASGP-1 has 
been postulated to be important to transplantability across strain and 
species barriers (Cooper~ al., 1974; Miller and Cooper, 1978b; Miller, 
Cooper and Brown, 1978a), we have investigated the mechanisms, rates 
and components of the shedding process. MAT-B1 and MAT-C1 cells shed 
cell surface material in both particulate and soluble forms. Moreover, 
shed components can be observed in the medium of cells incubated in 
vitro or in ascites fluid removed directly from the animal. Although 
morphologically identifiable cell surface structures (e.g. microvilli) 
can be observed in the medium after shedding in vitro, no discrete 
structural elements are observed in ascites fluid. Thus it appears that 
shed structural elements break down in the ascites fluid. The structures 
and amounts of particulate surface products are quite similar for MAT-Bl 
and MAT-Cl cells in vivo, suggesting that shedding of particulate material 
is unlikely to account for biological differences between the sublines. 
Since gel filtration in SDS has shown that the soluble shed form of 
Figure 27. ( 125 r]PNA Assay for MAT-C1 and MAT-B1 ( 0, .. ) ASGP-1. 
Samples were electrophoresed and stained with [125r)PNA. 
ASGP-1 bands were then cut out and counted for radio-
activity using a gamma counter. Protein values are based 
on a Lowry determination (Lowry et al., 1951). 
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ASGP-1 is smaller than purified ASGP-1, which is approximately the same 
size as ASGP-1 released directly from cells by SDS treatment (Howard et 
al., submitted for publication; Sherblom, Buck and Carraway, 1980a), we 
suggest that release of ASGP-1 occurs by proteolytic cleavage. Removal 
of a portion of the polypeptide chain would not necessarily affect 
migration on SDS polyacrylamide gel electrophoresis where the detergent 
binding and charge of the sialic acid are important factors, but would 
probably alter the Stokes radius of the glycoprotein, which determines 
gel filtration behavior. The mode of binding of ASGP-1 to the membrane 
is unknown. One possibility is that a hydrophobic segment of ASGP-1 binds 
to the membrane bilayer. Release could occur by proteolytic cleavage of 
the polypeptide at a point between the membrane attachment and the bulk 
of the carbohydrate. This model, depicted in Figure 28, is similar to 
those postulated for cytochrome b5 (Strittmatter, Rogers and Spatz, 1972) 
and erythrocyte glycophorin. However, since the sialoglycoprotein of 
MAT-C1 cells appears to be present in fibrillar structures on the cell 
surface (Sherblom et al., 1980c), it is questionable whether it interacts 
directly with the membrane. An alternate possibility is that ASGP-1 
exists in polymerized form on the cell surface, interacting with the 
membrarte via a coupling molecule (Figure 28), possibly ASGP-2 (Sherblom, 
unpublished observations). This mechanism of binding could more readily 
explain the release of ASGP-l from membranes by the hydrophilic protein 
denaturants (urea, guanidine hydrochloride), and by nonionic detergents. 
The question of the importance of shedding to the survival of the 
tumor cells is still unsettled. The rates of shedding of both particulate 
and soluble labeled components are quit~ similar for.the two sublines in 
vitro, but the MAT-C1 subline has a 2.5-fold greater amount of soluble 
Figure 28. Alternate Models for the Release of Soluble ASGP-1 from 
Ascites Cell Surfaces. ASGP-1, the branched structure, is 
shown either (top view) extending into the bilayer or 
associated with a coupling molecule (bottom). In either 
case soluble ASGP-1 is released by proteolytic cleavage. 
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ASGP-1 in the ascites fluid than does MAT-Bl. This result indicates that 
the relative rates of shedding of soluble material must be different in 
vivo or, more likely, that other processes are important in determining 
the amount of soluble ASGP-1 in ascites fluid. Regardless, these 
quantitative differences in ascites fluid glycoprotein do not appear 
sufficient to account for transplantation differences between the sub-
lines. Thus our results do not provide positive evidence that shedding 
of sialoglycoproteins is a major factor for the 13762 tumor in permitting 
transplantation across histocompatibility barriers, as suggested for the 
TA3 manwary adenocarcinoma (Cooper , Codington and Brown, 1974; Miller 
and Cooper; 1978b; Miller, Cooper and Brown, 1978a), unless the shedding 
processes differ significantly for the sublines in the foreign host 
animal. We feel that it is more likely that other processes instead of 
or in addition to shedding are involved in escaping transplantation 
rejection. Further studies of this and similar systems are necessary to 
try to define these factors. 
CHAPTER V 
SUMMARY 
Glycoproteins of a cultured form (13762 MR) of the 1~762 rat manunary 
adenocarcinoma and its variants have been studied by analyses for peanut 
agglutinin (PNA) receptors, [ 3H]glucosamine labeling, lactoperoxidase 
labeling and CsCl density gradient centrifugation. The 13762 MR cells, 
derived from 13762 MAT-B ascites cells, do not contain detectable ASGP-1, 
the predominant cell surface sialoglycoprotein of the ascites forms of 
the 13762 tumor. Transplantation and continued passages as ascites cells 
or MR cells or clonal lines derived from MR results in expression of 
ASGP-1, even though it is absent in early passages of the tumor. When 
these ascites cells are transferred to culture, ASGP-1 is again lost. No 
\ . 
ASGP-1 is found in solid tumors derived from subcutaneous transplantation 
of the 13762 tumor cells, although clonal selection of populations with 
and without ASGP-1 cannot be unequivocally ruled out. 
Two 13762 MR variant ascites cell lines, MAT-MR2-S and MAT-cMR6-S 
have been established through transplantation of the 13762 MR cells and 
a 13762 MR clone into F344 female rats. Both ascites lines have been 
partially characterized and differ from each other and from the previously 
established 13762 mammary adenocarcinoma ascites lines, including the 
MAT-B1 and MAT-C1 cells. 
Because the shedding of cell surface components has been invoked as 
104 
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a factor in the survival of tumor cells in a foreign host, the shedding 
processes in the xenotransplantable NAT-C1 and nonxenotransplantable 
MAT-B1 rat mammary adenocarcinoma sublines have been investigated. Using 
cells labeled in vivo with [ 3H]glucosamine, it was shown that both sub-
lines shed particulate and soluble cell surface material containing one 
predominant labeled component, the sialoglycoprotein ASGP-1. The rates 
of shedding of both particulate and soluble label are very similar for 
the two sublines, but the turnover of label in the cells was 80% greater 
forMAT-C1 cells (t1 2.4 da) than forMAT-B1 cells (t1 4.1 da). Based ~ ~ 
on eH]leucine incorporation, MAT-Bl ASGP-1 has a lower rate of synthesis 
than MAT-cl ASGP-1. The release of th.e soluble form of ASGP-1 is de-
creased by the protease inhibitor Aprotinin or the addition of EDTA. 
Since coworkers have shown that ASGP-1 is sensitive to proteolytic 
cleavage (Buck, 1978) and that soluble ASGP-1 isolated either from 
ascites fluid or after in vitro incubation of ascites cells is smaller 
than ASGP-1 isolated from plasma membrane vesicles (Howard et al., 
submitted for publication), the accumulated evidence suggests that soluble 
ASGP-1 arises from proteolytic cleavage. The MAT-Cl ascites fluid con-
tained 2.5-fold more soluble ASGP-1 per mg protein than did }1AT-Bl. The 
amounts of shed particulate material in ascites fluid were similar for the 
two sublines, and no substantial morphological differences were observed 
for these particulate fractions by scanning electron microscopy. The 
results of these studies indicate that it is unlikely that shedding of 
prominent cell surface components contributes significantly to differences 
in ability of these tumors to transplant across species barriers. 
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